Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Administered With the Single High-Dose Bolus Versus Abciximab and Sirolimus Eluting Stent Versus Bare Metal Stent in Acute Myocardial Infarction - MULTI-STRATEGY Trial

NCT00229515 is registered in ClinicalTrials.gov with Marco Valgimigli as lead sponsor.

NCT NCT00229515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00229515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Administered With the Single High-Dose Bolus Versus Abciximab and Sirolimus Eluting Stent Versus Bare Metal Stent in Acute Myocardial Infarction - MULTI-STRATEGY Trial
Lead sponsor
Marco Valgimigli
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2004
Completion date
March 31, 2012
Enrollment
744 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction